Immunity unmasks APOL1 in collapsing glomerulopathy

被引：6
|
作者：
McNicholas, Bairbre A. [1 ,2 ]
Nelson, Peter J. [1 ,2 ]
机构：
[1] Univ Washington, Div Nephrol, Seattle, WA 98195 USA
[2] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA
来源：
KIDNEY INTERNATIONAL | 2015年 / 87卷 / 02期
关键词：
cytokines; glomerulus; inflammation; podocyte; renal pathology; signaling; KIDNEY-DISEASE; ALPHA;
D O I：
10.1038/ki.2014.325
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Collapsing glomerulopathy predominantly afflicts patients of African ancestry, often first presenting after the immune system is engaged by another disorder. Nichols et al. now show that collateral induction of pathogenic APOL1 allelic variants in podocytes by the ongoing immune response may be the long-sought-after explanation for the development of collapsing glomerulopathy in these patients.
引用
收藏
页码：270 / 272
页数：3
相关论文
共 50 条
  • [21] APOL1 at 10 years: progress and next steps
    Freedman, Barry, I
    Kopp, Jeffrey B.
    Sampson, Matthew G.
    Susztak, Katalin
    KIDNEY INTERNATIONAL, 2021, 99 (06) : 1296 - 1302
  • [22] APOL1 Sends Its REGARDS to Cardiovascular Disease
    Waitzman, Joshua S.
    Wilkins, John T.
    Lin, Jennie
    CIRCULATION-GENOMIC AND PRECISION MEDICINE, 2018, 11 (06):
  • [23] APOL1 and Nephropathy Progression in Populations of African Ancestry
    Freedman, Barry I.
    SEMINARS IN NEPHROLOGY, 2013, 33 (05) : 425 - 432
  • [24] Clinical Genetic Testing for APOL1: Are we There Yet?
    Young, Bessie A.
    Fullerton, Stephanie Malia
    Wilson, James G.
    Cavanaugh, Kern
    Blacksher, Erika
    Spigner, Clarence
    Himmelfarb, Jonathan
    Burke, Wylie
    SEMINARS IN NEPHROLOGY, 2017, 37 (06) : 552 - 557
  • [25] Recessive, gain-of-function toxicity in an APOL1 BAC transgenic mouse model mirrors human APOL1 kidney disease
    McCarthy, Gizelle M.
    Blasio, Angelo
    Donovan, Olivia G.
    Schaller, Lena B.
    Bock-Hughes, Althea
    Magraner, Jose M.
    Suh, Jung Hee
    Tattersfield, Calum F.
    Stillman, Isaac E.
    Shah, Shrijal S.
    Zsengeller, Zsuzsanna K.
    Subramanian, Balajikarthick
    Friedman, David J.
    Pollak, Martin R.
    DISEASE MODELS & MECHANISMS, 2021, 14 (08)
  • [26] Protein domains of APOL1 and its risk variants
    Lan, Xiqian
    Wen, Hongxiu
    Lederman, Rivka
    Malhotra, Ashwani
    Mikulak, Joanna
    Popik, Waldemar
    Skorecki, Karl
    Singhal, Pravin C.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2015, 99 (01) : 139 - 144
  • [27] APOL1 channel blocker reduces proteinuria in FSGS
    Olabisi, Opeyemi A.
    KIDNEY INTERNATIONAL, 2023, 104 (02) : 228 - 230
  • [28] Nonpodocyte Roles of APOL1 Variants: An Evolving Paradigm
    Pell, John
    Nagata, Soichiro
    Menon, Madhav C.
    KIDNEY360, 2023, 4 (09): : 1325 - 1331
  • [29] APOL1 nephropathy - a population genetics success story
    Tabachnikov, Orly
    Skorecki, Karl
    Kruzel-Davila, Etty
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2024, 33 (04) : 447 - 455
  • [30] Characterization of circulating APOL1 protein complexes in African Americans
    Weckerle, Allison
    Snipes, James A.
    Cheng, Dongmei
    Gebre, Abraham K.
    Reisz, Julie A.
    Murea, Mariana
    Shelness, Gregory S.
    Hawkins, Gregory A.
    Furdui, Cristina M.
    Freedman, Barry I.
    Parks, John S.
    Ma, Lijun
    JOURNAL OF LIPID RESEARCH, 2016, 57 (01) : 120 - 130
12345